Skip to main content Accessibility help

A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age

  • Gemma E. Walton (a1), Ellen G. H. M. van den Heuvel (a2), Marit H. W. Kosters (a2), Robert A. Rastall (a1), Kieran M. Tuohy (a1) and Glenn R. Gibson (a1)...


Faecal microbial changes associated with ageing include reduced bifidobacteria numbers. These changes coincide with an increased risk of disease development. Prebiotics have been observed to increase bifidobacteria numbers within humans. The present study aimed to determine if prebiotic galacto-oligosaccharides (GOS) could benefit a population of men and women of 50 years and above, through modulation of faecal microbiota, fermentation characteristics and faecal water genotoxicity. A total of thirty-seven volunteers completed this randomised, double-blind, placebo-controlled crossover trial. The treatments – juice containing 4 g GOS and placebo – were consumed twice daily for 3 weeks, preceded by 3-week washout periods. To study the effect of GOS on different large bowel regions, three-stage continuous culture systems were conducted in parallel using faecal inocula from three volunteers. Faecal samples were microbially enumerated by quantitative PCR. In vivo, following GOS intervention, bifidobacteria were significantly more compared to post-placebo (P = 0·02). Accordingly, GOS supplementation had a bifidogenic effect in all in vitro system vessels. Furthermore, in vessel 1 (similar to the proximal colon), GOS fermentation led to more lactobacilli and increased butyrate. No changes in faecal water genotoxicity were observed. To conclude, GOS supplementation significantly increased bifidobacteria numbers in vivo and in vitro. Increased butyrate production and elevated bifidobacteria numbers may constitute beneficial modulation of the gut microbiota in a maturing population.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age
      Available formats


Corresponding author

*Corresponding author: G. E. Walton, fax +44 118 931 0080, email


Hide All
1 Macfarlane, GT, Macfarlane, S & Gibson, GR (1998) Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colonic microbiota. Microb Ecol Health Dis 35, 180187.
2 Macfarlane, GT, Gibson, GR & Cummings, JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72, 5764.
3 Bajka, BH, Clarke, JM, Cobiac, L, et al. (2008) Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats. Carcinogenesis 29, 21692174.
4 Lin, HC & Visek, WJ (1991) Colon mucosal cell damage by ammonia in rats. J Nutr 121, 887893.
5 Macfarlane, S & Macfarlane, GT (1995) Proteolysis and amino acid fermentation. In Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, pp. 75100 [Gibson, GR and Macfarlane, GT, editors]. Boca Raton, FL: CRC Press.
6 Woodmansey, EJ (2007) Intestinal bacteria and ageing. J Appl Microbiol 102, 11781186.
7 Mäkivuokko, H, Tiihonen, K, Tynkkynen, S, et al. (2010) The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br J Nutr 103, 227234.
8 Mueller, S, Saunier, K, Hanisch, C, et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 10271033.
9 Rajilic-Stojanovic, M, Heilig, HGHJ, Molenaar, D, et al. (2009) Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of the universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11, 17361751.
10 Hopkins, MJ, Sharp, R & Macfarlane, GT (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48, 198205.
11 Hopkins, MJ & Macfarlane, GT (2002) Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, 448454.
12 Zwielehner, J, Liszt, K, Handschur, M, et al. (2009) Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44, 440446.
13 Biagi, E, Nylund, L, Candela, M, et al. (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 5, e10667.
14 Lay, C, Rigottier-Gois, L, Holmstrøm, K, et al. (2005) Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 71, 4153–4145.
15 Claesson, M, Cusack, S, O'Sullivan, O, et al. (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 108, (Suppl. 1), 45864591.
16 Cai, J, Clark, J, Croft, S, et al. (2008) Indications of Public Health in the English Regions: Older People. York: Association of Public Health Observatories.
17 Woodmansey, EJ, McMurdo, ME, Macfarlane, GT, et al. (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 61136122.
18 Bartosch, S, Fite, A, Macfarlane, GT, et al. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70, 35753581.
19 Saunier, K & Doré, J (2002) Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis 34, 1924.
20 Gibson, GR, Scott, KP, Rastall, RA, et al. (2010) Dietary prebiotics: current status and new definition. FST Bull 7, 119.
21 Silk, DBA, Davis, A, Vulevic, J, et al. (2009) Clinical trial: the effect of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29, 508518.
22 Vulevic, J, Drakoularakou, A, Yaqoob, P, et al. (2008) Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 14381446.
23 Depeint, F, Tzortzis, G, Vulevic, J, et al. (2008) Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 87, 785791.
24 Bouhnik, Y, Raskine, L, Simoneau, G, et al. (2004) The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose–response relation study. Am J Clin Nutr 80, 16581664.
25 Ito, M, Deguchi, Y, Miyamori, A, et al. (1990) Effects of administration of galacto-oligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 3, 285292.
26 Gopal, PK, Prasad, J & Gill, HS (2003) Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galacto-oligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutr Res 23, 13131328.
27 Fanaro, S, Marten, B, Bagna, R, et al. (2009) Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr 48, 8288.
28 Probert, HM, Apajalahti, JH, Rautonen, N, et al. (2004) Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl Environ Microbiol 70, 45054511.
29 Franks, AH, Harmsen, HJM, Raangs, GC, et al. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 33363345.
30 Ritalahti, KM, Amos, BK, Sung, Y, et al. (2006) Quantitative PCR targeting 16S rRNA and reductive dehalogenase genes simultaneously monitors multiple Dehalococcoides strains. Appl Environ Microbiol 72, 27652774.
31 Nauta, A, van den Heuvel, EGHM & Veurink, JH, et al. (2008) Lactobacillus – the invention provides means and methods for detecting, amplifying, quantifying and/or isolating nucleic acid of at least one Lactobacillus organism. European patent EP 1 997 906 A1.
32 Nauta, A, van den Heuvel, EGHM & Veurink, JH, et al. (2008) Bifidobacterium – the invention provides means and methods for detecting, amplifying, quantifying and/or isolating nucleic acid of at least one member of Bifidobacterium. European patent EP 1 997 907.
33 Gill, CI, Haldar, S, Porter, S, et al. (2004) The effect of cruciferous and leguminous sprouts on genotoxicity, in vitro and in vivo. Cancer Epidemiol Biomarkers Prev 13, 11991205.
34 Macfarlane, GT & Gibson, GR (1997) Carbohydrate fermentation, energy transduction, and gas metabolism in the human large intestine. In Gastrointestinal Microbiology, pp. 269318 [Mackie, RI and White, BA, editors]. London: Chapman and Hall.
35 Pereira, DI & Gibson, GR (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68, 46894693.
36 Tuohy, KM, Kolida, S, Lustenberger, AM, et al. (2001) The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides – a human volunteer study. Br J Nutr 86, 341348.
37 Bouhnik, Y, Achour, L, Paineau, D, et al. (2007) Four-week short chain fructo-oligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Nutr J 6, 4249.
38 Bartosch, S, Woodmansey, EJ, Paterson, JC, et al. (2005) Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 40, 2837.
39 Surakka, A, Kajander, K, Rajilić-Stojanović, M, et al. (2009) Yoghurt containing galactooligosaccharides facilitates defecation among elderly subjects and selectively increases the number of bifidobacteria. Int J Prob Preb 4, 6574.
40 Wilson, KH & Blitchington, RB (1996) Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62, 22732278.
41 Apajalahti, JH, Kettunen, A, Nurminen, PH, et al. (2003) Selective plating underestimates abundance and shows differential recovery of bifidobacterial species from human feces. Appl Environ Microbiol 69, 57315735.
42 Kolida, S & Gibson, GR (2007) Prebiotic capacity of inulin-type fructans. J Nutr 137, (Suppl. 11), 2503S2506S.
43 Toden, S, Bird, AR, Topping, DL, et al. (2007) Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids. Cancer Biol Ther 6, 253258.
44 Langkilde, AM, Champ, M & Andersson, H (2002) Effects of high-resistant-starch banana flour (RS(2)) on in vitro fermentation and the small-bowel excretion of energy, nutrients, and sterols: an ileostomy study. Am J Clin Nutr 75, 104111.
45 Brinkworth, GD, Noakes, M, Clifton, PM, et al. (2009) Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 101, 14931502.
46 Duncan, SH, Belenguer, A, Holtrop, G, et al. (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73, 10731078.
47 Muir, JG & O'Dea, K (1993) Validation of an in vitro assay for predicting the amount of starch that escapes digestion in the small intestine of humans. Am J Clin Nutr 57, 540546.
48 Evenepoel, P, Claus, D, Geypens, B, et al. (1999) Amount and fate of egg protein escaping assimilation in the small intestine of humans. Am J Physiol 277, G935G943.
49 Cani, PD & Delzenne, NM (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15, 15461558.
50 Benassi, B, Leleu, R, Bird, T, et al. (2007) Cytokinesis-block micronucleus cytome assays for the determination of genotoxicity and cytotoxicity of cecal water in rats and fecal water in humans. Cancer Epidemiol Biomarkers Prev 16, 26762680.
51 Singh, NP, McCoy, MT, Tice, RR, et al. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175, 184191.
52 Pearson, JR, Gill, CI & Rowland, IR (2009) Diet, fecal water, and colon cancer–development of a biomarker. Nutr Rev 67, 509526.
53 Glei, M, Habermann, N, Osswald, K, et al. (2005) Assessment of DNA damage and its modulation by dietary and genetic factors in smokers using the Comet assay: a biomarker model. Biomarkers 10, 203217.
54 Oßwald, K, Becker, TW, Grimm, M, et al. (2000) Inter- and intra-individual variation of faecal water – genotoxicity in human colon cells. Mutat Res 472, 5970.
55 Sharp, R, Fishbain, S & Macfarlane, GT (2001) Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro. J Med Microbiol 50, 152160.
56 Gibson, GR & Wang, X (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77, 412420.
57 Belenguer, A, Duncan, SH, Calder, AG, et al. (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72, 35933599.
58 Duncan, SH, Barcenilla, A, Stewart, CS, et al. (2002) Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 68, 51865190.
59 Roediger, WE (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793798.
60 Hill, MJ (1995) Introduction: dietary fibre, butyrate and colorectal cancer. Eur J Cancer Prev 4, 341343.
61 Singh, B, Halestrap, AP & Paraskeva, C (1997) Butyrate can act as a stimulator of growth or an inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis 18, 12651270.
62 Knudsen, KEB, Serena, A, Canibe, N, et al. (2003) New insights into butyrate metabolism. Proc Nutr Soc 62, 8186.
63 Pool-Zobel, BL, Selvaraju, V, Sauer, J, et al. (2005) Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 26, 10641076.
64 Nadkarni, MA, Martin, FE, Jacques, NA, et al. (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148, 257266.
65 Institute of Grocery Distribution (2005) Review of Existing and Development of New GDAs: Decisions and Rationale Report of the IGD/PIC Industry Nutrition Strategy Group. Hertfordshire, UK.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed